Literature DB >> 17499232

Globular and full-length forms of adiponectin mediate specific changes in glucose and fatty acid uptake and metabolism in cardiomyocytes.

Rengasamy Palanivel1, Xiangping Fang, Min Park, Megumi Eguchi, Shelley Pallan, Sabrina De Girolamo, Ying Liu, Yu Wang, Aimin Xu, Gary Sweeney.   

Abstract

OBJECTIVE: Our aim was to investigate the regulation of glucose and fatty acid metabolism in cardiomyocytes by the globular (gAd) and full-length (fAd) forms of adiponectin.
METHODS: We produced fAd (consisting of high, medium and low molecular weight oligomers) in a mammalian expression system and gAd in bacteria. These were used to treat primary neonatal rat cardiomyocytes (up to 48 h), and we employed 3H- or 14C-labeled substrates to monitor glucose uptake and subsequent metabolism via oxidation, glycogen synthesis or lactate production and fatty acid uptake and oxidation. Enzymatic assay for acetyl CoA carboxylase activity was employed, and protein phosphorylation and expression was determined by immunoblotting cell lysates. The role of adiponectin receptor (AdipoR) isoforms was determined via siRNA-mediated knockdown.
RESULTS: There was an initial (1 h) increase in glucose uptake and oxidation in response to gAd or fAd. Fatty acid uptake was stimulated by gAd or fAd, and by 24 h a decrease in acetyl CoA carboxylase activity and elevated fatty acid oxidation were observed. After 48 h increased fatty acid oxidation correlated with decreased glucose oxidation and pyruvate dehydrogenase activity, while glycogen synthesis and lactate production increased. Both gAd and fAd elicited phosphorylation of AMP kinase, insulin receptor substrate-1, Akt and glycogen synthase kinase-3beta. Knockdown of AdipoR1 or AdipoR2 attenuated the effect of both gAd and fAd on fatty acid uptake and oxidation. Only AdipoR1 knockdown prevented the ability of gAd (1 h) to increase glucose uptake and oxidation; however, reducing either AdipoR1 or AdipoR2 expression attenuated the long-term (24 h) effects of gAd.
CONCLUSIONS: These results clearly demonstrate that gAd and fAd mediate distinct and time-dependent effects on cardiomyocyte energy metabolism via AdipoR1 and AdipoR2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17499232     DOI: 10.1016/j.cardiores.2007.04.011

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  36 in total

1.  An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart.

Authors:  Xiangping Fang; Rengasamy Palanivel; Justin Cresser; Kristin Schram; Riya Ganguly; Farah S L Thong; Joseph Tuinei; Aimin Xu; E Dale Abel; Gary Sweeney
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-08-24       Impact factor: 4.310

2.  C1q tumor necrosis factor alpha-related protein isoform 5 is increased in mitochondrial DNA-depleted myocytes and activates AMP-activated protein kinase.

Authors:  Seung-Yoon Park; Jung Hyun Choi; Hyun Su Ryu; Youngmi Kim Pak; Kyong Soo Park; Hong Kyu Lee; Wan Lee
Journal:  J Biol Chem       Date:  2009-08-03       Impact factor: 5.157

Review 3.  Nutrient sensing and utilization: Getting to the heart of metabolic flexibility.

Authors:  Timothy M Griffin; Kenneth M Humphries; Michael Kinter; Hui-Ying Lim; Luke I Szweda
Journal:  Biochimie       Date:  2015-10-22       Impact factor: 4.079

Review 4.  The role of adiponectin signaling in metabolic syndrome and cancer.

Authors:  Michael P Scheid; Gary Sweeney
Journal:  Rev Endocr Metab Disord       Date:  2014-06       Impact factor: 6.514

5.  Adiponectin stimulates proliferation of adult hippocampal neural stem/progenitor cells through activation of p38 mitogen-activated protein kinase (p38MAPK)/glycogen synthase kinase 3β (GSK-3β)/β-catenin signaling cascade.

Authors:  Di Zhang; Ming Guo; Wei Zhang; Xin-Yun Lu
Journal:  J Biol Chem       Date:  2011-10-28       Impact factor: 5.157

6.  Lipocalin-2 induces cardiomyocyte apoptosis by increasing intracellular iron accumulation.

Authors:  Guoxiong Xu; Jinhee Ahn; Soyoung Chang; Megumi Eguchi; Arnaud Ogier; Sungjun Han; Youngsam Park; Chiyoung Shim; Yangsoo Jang; Bo Yang; Aimin Xu; Yu Wang; Gary Sweeney
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

7.  Globular adiponectin ameliorates metabolic insulin resistance via AMPK-mediated restoration of microvascular insulin responses.

Authors:  Lina Zhao; Zhuo Fu; Jing Wu; Kevin W Aylor; Eugene J Barrett; Wenhong Cao; Zhenqi Liu
Journal:  J Physiol       Date:  2015-07-26       Impact factor: 5.182

Review 8.  Review: Adiponectin--the missing link between maternal adiposity, placental transport and fetal growth?

Authors:  I L M H Aye; T L Powell; T Jansson
Journal:  Placenta       Date:  2012-12-13       Impact factor: 3.481

9.  Adiponectin downregulation is associated with volume overload-induced myocyte dysfunction in rats.

Authors:  Li-li Wang; Dori Miller; Desiree Wanders; Gayani Nanayakkara; Rajesh Amin; Robert Judd; Edward E Morrison; Ju-ming Zhong
Journal:  Acta Pharmacol Sin       Date:  2015-11-30       Impact factor: 6.150

Review 10.  Genetics-based manipulation of adipose tissue sympathetic innervation.

Authors:  Marie François; Emily Qualls-Creekmore; Hans-Rudolf Berthoud; Heike Münzberg; Sangho Yu
Journal:  Physiol Behav       Date:  2017-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.